TissueGene has completed enrolling patients in a US-based Phase II trial of its TG-C therapy, designed to treat patients with Grade 3 chronic degenerative joint disease (DJD) of the knee. Comprising human allogeneic chondrocytes, the TG-C ...
Tags: TG-C therapy, therapeutic protein, TG-C
METALLOINVEST has won the PEOPLE INVESTOR 2012 corporate competition for the best regional project in the “building relations with partner and client relations” category. The Company’s project in the “personal ...
Tags: Metalloinvest, People Investor 2012, personal protective equipment
Dubai Aluminium the entirely state-owned entity that operates the world's largest single site primary aluminium smelter using pre baked anode technology signed an agreement with Aluminium Bahrain BSC whereby the latter will use Dubal's DX+ ...
Tags: Dubai Aluminium, primary aluminium, aluminium, anode technology
Boeing lands$16M laser weapon follow-up 08 Oct 2012 Defense contractor agrees follow-on contract with US Army Space and Missile Command for 10kW solid-state system. Boeing is to develop a truck-mounted 10kW laser weapon for the US Army. ...
Tags: laser weapons, US Army Space and Missile, 10kW solid-state system
Sulzer Pumps will supply 40 pumps to PetroChina, the largest oil producer in China for the Guangxi Oil Refinery Project Phase II. Located in the Guangxi Province in Southern China, the project will refine imported high sulfur crude oil. ...
Tags: Sulzer Pumps, PetroChina, Guangxi Oil Refinery Project
Teva Women's Health, a US-based subsidiary of Teva Pharmaceutical Industries, has announced FDA acceptance of its Quartette new drug application (NDA). The company is seeking approval to manufacture and market Quartette ...
Tags: ethinyl estradiol tablets, market Quartette, contraceptive products
The United States Patent and Trademark Office has issued a patent for Lorus Therapeutics' LOR-253, which covers composition of matter and methods of treating cancer. The patent was initially set to expire in May 2026 and latter was ...
The US Food and Drug Administration (FDA) has accepted Avanir Pharmaceuticals' investigational new drug (IND) application for the study of AVP-923, an investigational drug for the treatment of agitation in patients with Alzheimer's disease. ...
Tags: AVP-923, Alzheimer's disease, IND
ElectroMech, India's largest industrial crane manufacturer and customized material handling solutions provider, was awarded the Excellence in Innovation award in the SME category for its specialized Tunnel Mucking System, by Manufacturing ...
Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
Business Line reported that Lanco Infratech Ltd has entered into a MoU with the China Development Bank, a bank owned by the Government of Peoples Republic of China. The MoU is to raise USD 2 billion debt for 2 power projects Anpara Phase ...
Tags: coal, gas, hydro, solar and wind, power projects
The US Food and Drug Administration (FDA) has granted fast track designation for Idenix Pharmaceuticals' IDX719 to treat chronic hepatitis C infection (HCV). IDX719 is an NS5A inhibitor that demonstrated pan-genotypic activity in a recent ...
Tags: IDX719, HCV, chronic hepatitis C infection
TMC's Indian subsidiary Toyota Kirloskar Motor (TKM) is planning to build mid-class luxury sedan Camry at its Bengaluru facility starting this July. As part of the phase-II expansion, the company aims to invest INR8.98bn ($175.16m) at the ...
Tags: Toyota Kirloskar Motor, luxury sedan, engine and transmission plant
Janssen-Cilag International has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval to use the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as ...
Tags: investigational drug bedaquiline, multi-drug resistant tuberculosis
Biotech has rceived a notice of allowance from the USPTO for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Once the patent is issued, PROLOR would gain additional intellectual ...
Tags: PROLOR, CTP platform, human growth hormone